I am curious as to how other facilities handle crossmatches on women who have had a previous "anti-D possibly due to Rhogam". Do you do full AHG crossmatches from that point on or do you do IS crossmatches after the anti-D is no longer demonstrating, and for those facilities that do electronic crossmatches, would you do an electronic crossmatch on these women or are they forever marked as having a clinically significant antibody? Thanks for any input.

We have a code in the computer identifying the anti-D as most likely the result of a RhIG injection. As long as we can detect the antibody we honor it with a coombs crossmatch. When it goes away we're back to IS crossmatches.

Ditto